Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2011
September 2011
Novartis Says Drug Improves COPD Symptoms
Novartis Says Drug Improves COPD Symptoms
FOX Business
COPD
Novartis
NVA237
FDA Panel, Bayer Birth Control Pills & Blood Clots
FDA Panel, Bayer Birth Control Pills & Blood Clots
Pharmalot
advisory panels
blood clots
birth control pill
FDA
Bayer
Yasmin
Yaz
Alexion, Celgene Resilient Vs. Volatile Market
Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Celgene
Alexion
Soliris
Revlimid
Statins for Primary Prevention: the Debate Continues
Statins for Primary Prevention: the Debate Continues
Forbes
statins
How Eli Lilly Will Outwit Patent Expirations
How Eli Lilly Will Outwit Patent Expirations
Seeking Alpha
patents
Eli Lilly
Medicis Settles Case Alleging CEO Shacknai Cooked the Books
Medicis Settles Case Alleging CEO Shacknai Cooked the Books
BNET Pharma
Medicis
Jonah Shacknai
2 Positive Signs for Ariad Pharmaceuticals
2 Positive Signs for Ariad Pharmaceuticals
Motley Fool
Ariad Pharmaceuticals
Swiss paper totes up Novartis layoff count: 2,500
Swiss paper totes up Novartis layoff count: 2,500
Fierce Pharma
Novartis
layoffs
Afinitor data could be 'game-changer' in breast cancer
Afinitor data could be 'game-changer' in breast cancer
Fierce Pharma
Afinitor
breast cancer
mTOR inhibitors
Pfizer
Aromasin
Bayer Drug Hailed As Prostate Cancer Game Changer
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
Bayer
prostate cancer
Algeta
Amgen
Xgeva
Exelixis
Alpharadin
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »